EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Comparison of In-Vitro and In-Vivo Drug Release of Dexamethasone/PLGA Intravitreal Implants Using Two In-Vitro Release Methods and a Rabbit Model

Coleman Johnson iD, Esther Maier, Aanya Bhalla, Eric Crowell, Yan Wang, Bin Qin, Feng Zhang iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c01076 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Coleman Johnson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, University of Texas at Austin, Austin, Texas 78712, United States. Hauptthemen laut MEDLINE: Dexamethasone, Drug Implants, Lactic Acid, Polyglycolic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural FDA HHS, Center for Drug Evaluation and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug delivery products based on poly(lactic-co-glycolic acid) (PLGA) are complex systems that may have significantly different drug release behavior under different release conditions, i.e., in different in vitro release tests (IVRTs) or in vivo. This must be appreciated when designing an IVRT for a given application. For example, when designing an IVRT for formulation development or bioequivalence testing, it is commonly desired that the IVRT is biorelevant to some extent, meaning that it imitates the relevant biological fluid/physiological environment ("compositional biorelevance") and by doing so simulates the in vivo release process ("mechanistic biorelevance"). Theoretically, biorelevance leads to "biopredictiveness," meaning that the IVRT predicts certain aspect(s) of in vivo performance. The objective of this study was to assess two IVRTs for dexamethasone/PLGA intravitreal implants according to a few selected aspects of biorelevance and biopredictiveness. These two IVRTs differed only in release medium composition: one used unbuffered isotonic saline, whereas the other used 12 mM phosphate-buffered saline (PBS) at pH 7.4. In the first part of this study, two different implant formulations were tested in these two IVRTs. The two implant formulations had the same composition and structure as each other but were manufactured using slightly different batches of PLGA. In the saline-based IVRT, the two formulations had similar in vitro release profiles, both lasting about 28 days; in the PBS-based IVRT, the two formulations had different release profiles, both lasting about 4 months. Next, these two implant formulations were injected into the left and right vitreous of 36 New Zealand White rabbits. In vivo drug release was measured directly by recovering implants at various timepoints and assaying their remaining drug content by high-pressure liquid chromatography (HPLC). Additionally, ocular pharmacokinetics were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The two implant formulations had similar in vivo release profiles and ocular pharmacokinetics as each other, and in vivo release lasted between 21 and 28 days; therefore, these in vivo results closely matched the saline-based IVRT. In the final part of this study, we endeavored to reconcile the saline-based IVRT's good prediction of in vivo release with the fact that the rabbit vitreous is buffered. This was investigated mechanistically by measuring the degradation of the implant's PLGA matrix during both in vitro and in vivo release. Matrix degradation was measured by recovering implant samples at various timepoints and measuring PLGA molecular weight by gel permeation chromatography. This was performed with one implant formulation in both IVRTs and in the vitreous of 4 rabbits. These measurements demonstrated that the PBS-based IVRT provided a better simulation of the implant's in vivo surface erosion, whereas the saline-based IVRT provided a better simulation of in vivo bulk erosion. Ultimately, we concluded that both IVRTs may provide value depending on the application: the saline-based IVRT may be preferred for predicting rabbit in vivo release, whereas the PBS-based IVRT may be preferred for a highly sensitive discriminatory test.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneDrug ImplantsLactic AcidPolyglycolic AcidRabbitsAnimalsPolylactic Acid-Polyglycolic Acid CopolymerDrug LiberationDrug Delivery SystemsIntravitreal InjectionsMale

Stichwörter der Autor:innen

OZURDEXdexamethasonein vivo releaseintravitreal implantpoly(lactic-co-glycolic acid) (PLGA)

Substanzen

DexamethasonePolylactic Acid-Polyglycolic Acid CopolymerDrug ImplantsLactic AcidPolyglycolic Acid

Autor:innen und Institutionen

  • Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, University of Texas at Austin, Austin, Texas 78712, United States.
  • Department of Ophthalmology, Dell Medical School, University of Texas at Austin, Austin, Texas 78701, United States.
  • Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20903, United States.

ORCID-Profile: Coleman Johnson, Feng Zhang

Förderung

  • Intramural FDA HHS
  • Center for Drug Evaluation and Research

Zitieren

APA

Johnson, C., Maier, E., Bhalla, A., Crowell, E., Wang, Y., Qin, B., & Zhang, F. (2025). Comparison of In-Vitro and In-Vivo Drug Release of Dexamethasone/PLGA Intravitreal Implants Using Two In-Vitro Release Methods and a Rabbit Model. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01076

Vancouver

Johnson C, Maier E, Bhalla A, Crowell E, Wang Y, Qin B, et al. Comparison of In-Vitro and In-Vivo Drug Release of Dexamethasone/PLGA Intravitreal Implants Using Two In-Vitro Release Methods and a Rabbit Model. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c01076

BibTeX
@article{Johnson2025,
  author = {Johnson, Coleman and Maier, Esther and Bhalla, Aanya and Crowell, Eric and Wang, Yan and Qin, Bin and Zhang, Feng},
  title = {Comparison of In-Vitro and In-Vivo Drug Release of Dexamethasone/PLGA Intravitreal Implants Using Two In-Vitro Release Methods and a Rabbit Model},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c01076}
}
Kostenlos starten →